Xanthine oxidoreductase in human mammary epithelial cells: activation in response to inflammatory cytokines.
Xanthine oxidoreductase (XOR) in human mammary epithelial cells was shown to have low true specific activity, similar to that in breast milk. Enzymic activity was increased in response to inflammatory cytokines; increases of 2-2.5-fold being seen with TNF-alpha and IL-1beta and of approximately 8-fold with IFN-gamma. No significant increase was seen with IL-6. A combination of IFN-gamma and TNF-alpha, or of these two cytokines plus IL-1beta, led to responses representing the sum of those obtained by using the individual cytokines. The 8-fold increase in enzymic activity, stimulated by IFN-gamma, corresponded to only a 2-3-fold increase in specific mRNA, suggesting the possibility of post-translational activation; a possibility strongly supported by the corresponding 2-3-fold rise in XOR protein, as determined by ELISA. In no case was cytokine-induced activation accompanied by changes in the oxidase-dehydrogenase ratio of XOR. These data strongly support a role for XOR in the inflammatory response of the human mammary epithelial cell, and provide further evidence of post-translational activation of a low activity form of human XOR, similar to that previously observed in vivo for the breast milk enzyme.
Page
S
S
Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK.
Powell
D
D
Benboubetra
M
M
Stevens
C R
CR
Blake
D R
DR
Selase
F
F
Wolstenholme
A J
AJ
Harrison
R
R
D001940:Breast / Q000187:drug effects / Q000201:enzymology*; D002460:Cell Line; D016207:Cytokines / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D004847:Epithelial Cells / Q000187:drug effects / Q000201:enzymology; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology; D008895:Milk, Human / Q000201:enzymology; D008982:Molybdenum / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014968:Xanthine Dehydrogenase / Q000235:genetics / Q000378:metabolism*; D014969:Xanthine Oxidase / Q000235:genetics / Q000378:metabolism*
D016207:Cytokines; D018836:Inflammation Mediators; D007375:Interleukin-1; D012333:RNA, Messenger; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; C044659:molybdate; D008982:Molybdenum; D007371:Interferon-gamma; D014968:Xanthine Dehydrogenase; D014969:Xanthine Oxidase